Ethionamide-induced gynecomastia

Dixit, Ramakant; George, Jacob; Sharma, Arun K.; chhabra, Naveen; Jangir, Suresh K.; Mishra, Vikas

doi:10.4103/0976-500X.95532

Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 3 | Issue 2 | 2012 | pp. 196–199Open access

Ethionamide-induced gynecomastia

¹^*,
¹,
²,
²,
¹,
¹

¹ Departments of Respiratory Medicine, College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.
² Pharmacology and Experimental Therapeutics, J. L. N. Medical College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.

Correspondence: Ramakant Dixit
Departments of Respiratory Medicine, College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.

Published:: Jan 1, 2012
DOI:: 10.4103/0976-500X.95532

How to cite

Dixit, R., George, J., Sharma, A. K., chhabra, N., Jangir, S. K., & Mishra, V. (2012). Ethionamide-induced gynecomastia. Journal of Pharmacology and Pharmacotherapeutics, 3(2), 196–199. https://doi.org/10.4103/0976-500X.95532

Abstract

Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.

Keywords

Subject

Article metadata

Title	Ethionamide-induced gynecomastia
Authors	Ramakant Dixit; Jacob George; Arun K. Sharma; Naveen chhabra; Suresh K. Jangir; Vikas Mishra
Affiliations	Departments of Respiratory Medicine, College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.; Pharmacology and Experimental Therapeutics, J. L. N. Medical College, Ajmer, India ABSTRACT Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. Key words: Antituberculosis therapy, drug-induced gynecomastia, ethionamide.
Journal	Journal of Pharmacology and Pharmacotherapeutics
Volume / Issue	Vol. 3, Issue 2 (2012)